Objectives. Although radical cystectomy remains the standard of care for invasive bladder
cancer in the United States, many groups are exploring the use of trimodality therapy using …

Purpose: Combined modality therapy has become the standard oncologic approach to
achieve organ preservation in many malignancies. Methods and Materials: Although radical …

Objectives. To evaluate the outcomes of patients with muscle-invasive Stage T2-4a bladder
carcinoma managed by transurethral surgery and concurrent chemoradiation. Methods. A …

PURPOSE: To evaluate our long-term experience with combined modality treatment and
selective bladder preservation and to identify factors that may predict treatment response …

PURPOSE To update the efficacy of a selective multimodality bladder-preserving approach
by transurethral resection (TURBT), systemic chemotherapy, and radiation therapy …

Standard treatment for muscle-invasive bladder cancer is cystectomy. Trimodality treatment,
including transurethral resection of the bladder tumor (TURBT), radiation therapy and …

Purpose: Radical cystectomy is considered as standard therapy for muscle-invasive bladder
cancer. We present 10-year results of bladder-sparing treatment by conservative surgery …

While radical cystectomy (RC) remains the standard of care for muscle‐invasive transitional
cell carcinoma of the bladder, a series of single‐institution and cooperative‐group trials with …

Purpose: To assess safety, tolerance, and disease control of transurethral resection of the
bladder tumor (TURB) plus concurrent cisplatin, 5-fluorouracil (5-FU), and radiation therapy …

Purpose For high-risk T1 bladder cancer, the most important issue is how to restrict radical
cystectomy to selective patients with a high likelihood of tumor progression and to choose an …